Concepedia
Statistics
Publications
4
Citations
273
H-Index
Active since
2002
Affiliations
GlaxoSmithKline (United States)(Current)
Orion Corporation (Finland)
Johnson & Johnson (United States)
Pfizer (United States)
Agnes Westelinck is an author at GlaxoSmithKline (United States) specializing in pharmacology, clinical pharmacology, and medicine.
Publications per year
2002–2012
Postmarketing drug dosage changes of 499 FDA‐approved new molecular entities, 1980–1999
James T. Cross, Howard Lee, Agnes Westelinck et al. · Pharmacoepidemiology and Drug Safety · 2002 · 139 citations
Medicine, Pharmacology, Clinical Pharmacology +13
Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan
Henry Malinowski, Agnes Westelinck, Junko Sato et al. · The Journal of Clinical Pharmacology · 2008 · 76 citations
Pharmacy, Pharmaceutical Policy, Pharmacology +7
Prospective–Retrospective Biomarker Analysis for Regulatory Consideration: white Paper from the Industry Pharmacogenomics Working Group
Scott D. Patterson, Nadine Cohen, Maha Karnoub et al. · Pharmacogenomics · 2011 · 47 citations
Medicine, Pharmacology, Drug Approval Processes +14
PhRMA Survey of Pharmacogenomic and Pharmacodynamic Evaluations: What Next?
N Grecco, Nadine Cohen, Amelia Warner et al. · Clinical Pharmacology & Therapeutics · 2012 · 11 citations
1–4 of 4